Over the last two decades the diagnostic tools used in sleep medicine
have developed enormously, making it possible to study the interaction
of sleep-related breathing disorders (SRBD) with cardiovascular funct
ion and the autonomic nervous system, as well as the effects of SRBD o
n a variety of physiological processes during wakefulness, Different m
odes of nasal ventilation are now available, allowing all forms of SRB
D to be treated, If early diagnosis and treatment are provided, the ac
ute and long-term sequelae of SRBD can be prevented. In addition to th
e care and treatment of patients with severe obstructive sleep apnoea
syndrome (OSAS), future patient management will need to focus on patie
nts with milder forms of obstructive sleep apnoea (OSA), In particular
, the consequences of SRBD on cardiac arrhythmias, arterial hypertensi
on and hypersomnolence are discussed, considering epidemiological, cli
nical, diagnostic and therapeutic aspects. Some economical issues aris
ing from SRBD are also discussed, and the authors conclude that a Euro
pewide programme for early detection, treatment and prevention of SRBD
is required. This could make a large contribution to the reduction of
cardiovascular morbidity and mortality and also reduce the incidence
of ''human error catastrophes'' due to hypersomnolence.